Biospecifics Technologies Corp (NASDAQ:BSTC)

Data as of Sep 19
 -0.20 / -0.60%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

BioSpecifics Technologies Corp. is a biopharmaceutical company, which engages in development of an injectable collagenase for multiple indications. Its product XIAFLEX is an injectable collagenase enzyme, which is used for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:



Individual stakeholders41.01%
Other institutional27.22%
Mutual fund holders14.77%

Top Executives

Thomas L. WegmanPresident, CEO, CFO, Director & CAO
Patrick CaldwellExecutive
James GorisController

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.